AJ Biologics ETEC vaccine

The AJ Biologics ETEC vaccine is a prophylactic vaccine candidate being developed or distributed by AJ Biologics, a Malaysian biotechnology company. It is designed to prevent infections caused by enterotoxigenic *Escherichia coli* (ETEC), which is a primary cause of bacterial diarrhea in children in developing countries and a leading cause of travelers' diarrhea. The vaccine is intended to induce protective immunity against ETEC strains to prevent the onset of diarrheal disease. While AJ Biologics lists ETEC as one of its four core vaccine focus areas, specific details regarding the vaccine's platform technology (such as inactivated whole-cell or subunit), molecular targets, and current clinical development phase are not publicly disclosed in the company's high-level pipeline information.

Other names

Enterotoxigenic E. coli vaccineETEC vaccine